4574 — Taiko Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Taiko Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6,098	3,505	5,484	4,532	4,256
Net Total Accounts Receivable
Net Total Receivables	4,056	1,798	1,985	2,428	2,450
Total Inventory
Total Other Current Assets
Total Current Assets	13,783	7,556	9,109	8,761	8,433
Net Property, Plant And Equipment	7,113	6,397	3,581	3,271	3,312
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	22,535	15,046	13,220	12,914	12,270
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4,320	2,793	3,046	2,855	2,509
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	9,728	7,002	6,481	4,950	3,752
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	12,807	8,044	6,739	7,964	8,518
Total Liabilities & Shareholders' Equity	22,535	15,046	13,220	12,914	12,270
Total Common Shares Outstanding